Cartiva Implant Lawsuit – Recall, Device Failures, and Legal Compensation

Cartiva Implant Lawsuits – What You Need to Know

The Cartiva Synthetic Cartilage Implant (SCI) was once marketed as a revolutionary option for patients suffering from big toe arthritis, a painful condition that limits mobility and quality of life. Designed to preserve motion and eliminate the need for traditional fusion surgery, the Cartiva implant seemed like a promising innovation. But in reality, thousands of patients across the country have reported severe pain, swelling, and implant failure-often requiring additional surgery to remove or fuse the toe joint. Following mounting evidence of widespread complications, Stryker Corporation issued a recall in October 2024. Since then, Cartiva lawsuits have accelerated as victims seek justice and compensation.

This page serves as the definitive resource on the topic-explaining what went wrong with the Cartiva implant, what lawsuits allege, the evidence driving litigation, and what victims can do to protect their rights. If you or a loved one experienced complications after receiving a Cartiva implant, you may be entitled to significant financial compensation.

What Is the Cartiva Synthetic Cartilage Implant?

The Cartiva SCI is a small cylindrical device, roughly the size of a pea, made of a hydrogel called polyvinyl alcohol (PVA). Its purpose is to replace the natural cartilage in the big toe joint (formally known as the first metatarsophalangeal joint), where arthritis causes bone-on-bone friction and chronic pain. The hydrogel material was designed to act like natural cartilage-compressible yet durable, allowing smoother motion and cushioning during walking or running.

Cleared by the FDA in 2016 through a pathway intended for devices “substantially equivalent” to existing procedures, Cartiva was positioned as a simpler, less invasive alternative to joint fusion (arthrodesis). For years, surgeons recommended it as a quick outpatient procedure with shorter recovery times and the ability to maintain toe movement. Unfortunately, many of those patients soon discovered that the promise didn’t match the performance.

Why the Cartiva Implant Fails

In practice, the Cartiva implant has shown a pattern of premature failure. Instead of behaving like permanent cartilage, the hydrogel tends to lose volume, harden, or shrink once implanted in the body. This shrinkage creates instability within the joint cavity, causing the implant to loosen, migrate, or fracture. Over time, patients develop intense pain, stiffness, and inflammation that often exceeds their pre-surgery discomfort.

Surgeons and patients have reported a wide range of complications, including:

• Shrinkage and migration: The implant contracts inside the bone, leading to dislocation or misalignment.
• Loosening and instability: Movement of the device causes bone wear and nerve irritation.
• Inflammation and osteolysis: The body reacts to the failing implant, eroding surrounding bone tissue.
• Implant fracture or fragmentation: The material breaks apart under pressure, requiring immediate removal.
• Infection, cysts, and granulomas: Resulting from tissue irritation and the breakdown of hydrogel material.

Many patients who initially underwent Cartiva implantation in hopes of avoiding fusion later found themselves forced to undergo it anyway. Fusion eliminates joint motion entirely, leaving the big toe stiff and immobile, but for many it was the only way to stop the persistent pain caused by implant failure.

The 2024 Cartiva Recall

After years of mounting complaints, medical literature, and FDA adverse event reports, Stryker Corporation recalled all Cartiva implants on October 31, 2024. The recall applied to every size-6mm, 8mm, 10mm, and 12mm-and covered all devices distributed since 2016. Surgeons were advised to return unused stock, and those with implanted devices were urged to monitor patients closely for symptoms of failure such as swelling, pain, or stiffness.

The recall came too late for many. Reports suggest that more than 60 percent of implants failed within just a few years, with some studies showing failure or revision rates as high as 79 percent. The FDA received more than 140 adverse event reports involving loosening, migration, and bone erosion before the recall. Despite these alarming signals, Stryker continued to market the device as safe and effective well into 2024.

For affected patients, the recall serves as critical evidence of negligence and design defects, strengthening the legal arguments being made in ongoing lawsuits nationwide.

Scientific Evidence of Cartiva Failure

The medical community’s growing concern about the Cartiva implant isn’t anecdotal-it’s supported by data. A 2024 study published out of King’s College Hospital in London compared Cartiva to traditional arthrodesis (fusion). The results were clear: patients who received Cartiva experienced a 29.4 percent reoperation rate, compared to zero percent among fusion patients. Other studies documented migration of the implant into bone, persistent pain, and early need for revision surgeries.

Even the original “Motion Study,” which the FDA relied upon for approval, has since been criticized. That trial involved a small, hand-picked patient group and only followed them for two years. Real-world evidence has shown much worse outcomes. Several prominent surgeons who participated in early trials have since stopped using the implant altogether due to unacceptable failure rates.

Lawsuits Against Stryker, Cartiva, and Wright Medical

Following the recall, hundreds of patients have filed Cartiva implant lawsuits against Stryker Corporation, Wright Medical Group N.V., and Cartiva, Inc. The lawsuits generally fall under product liability law and claim that the companies:

• Designed and sold a defective and unreasonably dangerous medical device
• Failed to properly test the implant before seeking FDA clearance
• Withheld evidence of device failures from the FDA and the public
• Failed to update warning labels or issue earlier recalls
• Misrepresented the device’s safety and durability in marketing materials

Most cases include claims for negligence, design and manufacturing defects, breach of warranty, and failure to warn. Some plaintiffs have added fraud and punitive damage claims, arguing that Stryker acted recklessly in continuing to sell the device despite internal data showing widespread complications. Punitive damages, if awarded, could significantly increase settlement values.

Current Status of Cartiva Litigation (2025)

As of late 2025, Cartiva lawsuits are being filed in both federal and state courts. The first trial is currently scheduled to begin in October 2025 in West Virginia, with additional cases pending in Maryland and across the country. Depending on how early trials unfold, the cases could be consolidated into a multidistrict litigation (MDL) to streamline discovery and negotiations.

Many attorneys familiar with defective implant litigation believe that Stryker will eventually pursue a global settlement to resolve these claims collectively, similar to other mass tort settlements the company has reached in the past involving hip and knee implants. Filing early ensures your case is included when settlement negotiations occur.

Who Qualifies for a Cartiva Implant Lawsuit?

You may be eligible to file a Cartiva lawsuit if you experienced complications or required revision surgery after receiving the implant. Qualifying injuries typically include:

• Persistent pain, swelling, or stiffness after Cartiva surgery
• Evidence of implant failure, migration, or fragmentation
• Revision surgery or joint fusion due to device failure
• Bone loss or nerve damage confirmed by imaging or surgical reports
• Significant medical expenses, lost wages, or lasting disability

Even if your symptoms appeared years after surgery, you may still have a valid claim. Each state has its own statute of limitations, but those time limits often start when you discover the injury-not necessarily when the implant was placed. Consulting a lawyer ensures your claim is filed before any deadlines expire.

What Compensation May Be Available?

The value of each Cartiva claim depends on the severity of injuries, the number of surgeries, and the extent of long-term disability. However, plaintiffs may pursue compensation for:

• Medical costs: Hospitalization, revision surgeries, physical therapy, medications, and long-term care
• Lost income: Missed work, reduced earning capacity, and loss of future wages
• Pain and suffering: Chronic pain, limited mobility, and loss of daily function
• Emotional distress: Anxiety, depression, and frustration caused by repeated medical procedures
• Loss of enjoyment of life: Inability to walk, exercise, or engage in family or recreational activities
• Punitive damages: In cases of gross negligence or corporate misconduct

While no two cases are identical, early legal analysis suggests that compensation could be significant-especially in cases requiring multiple surgeries or permanent loss of mobility.

How to Strengthen Your Cartiva Claim

Successful cases are built on solid documentation. Patients considering a Cartiva lawsuit should begin gathering evidence as soon as possible, including:

• Operative and surgical reports detailing implantation and revision procedures
• Implant identification stickers or serial numbers
• X-rays, MRIs, or CT scans showing device movement or bone loss
• Doctor’s notes describing symptoms, pain levels, and diagnosis of implant failure
• Records of all related medical costs and lost wages
• Personal journals or statements describing daily pain and limitations

Law firms experienced in medical device litigation will often obtain these records on your behalf. The sooner you contact counsel, the easier it is to preserve and organize this evidence before it’s lost or destroyed.

What Happens After You File a Cartiva Lawsuit?

Once a claim is filed, your attorney will handle every step of the process, from gathering expert testimony to negotiating potential settlements. Here’s a typical timeline:

1. Case review and filing: Your lawyer reviews your medical history, confirms implant details, and files the complaint.
2. Discovery phase: Both sides exchange documents and take depositions of company representatives, surgeons, and expert witnesses.
3. Bellwether trials: A few early cases proceed to trial to test legal arguments and assess jury reactions.
4. Global settlement: If the trials go favorably for plaintiffs, the manufacturer may negotiate a settlement for all remaining cases.
5. Distribution: Approved settlements are distributed based on injury severity, revision surgeries, and other factors.

Most product liability cases resolve through settlement before trial, but the process can take several months to several years. Working with an experienced firm ensures your case remains on track.

Our Commitment to Cartiva Victims

Our firm has represented clients in major defective implant cases against some of the world’s largest manufacturers. We understand how devastating it is to go through repeated surgeries and constant pain after trusting a medical product. Our attorneys collaborate with orthopedic experts and economists to accurately calculate damages, ensuring you’re compensated for every loss.

We work on a contingency basis-meaning you pay nothing unless we win. Our mission is to hold negligent companies accountable and help you regain financial stability after a medical device failure that never should have happened.

Injured by a Failed Cartiva Implant? Call Alonso Krangle, LLP Today

If your Cartiva Synthetic Cartilage Implant failed or you’re experiencing pain, swelling, or stiffness after surgery, Alonso Krangle, LLP can help. Our attorneys represent patients nationwide in claims against Stryker and Cartiva, holding them accountable for defective medical devices that cause lasting harm.

Call 800-403-6191 or contact Alonso Krangle, LLP online for a free, no-obligation consultation. There are no upfront fees, and you pay nothing unless we win your case.

Frequently Asked Questions About Cartiva Lawsuits

Is the Cartiva implant recalled?

Yes. Stryker recalled all Cartiva Synthetic Cartilage Implants in October 2024 due to high failure rates, shrinkage, and migration issues. The recall affects every implant size and production year since 2016.

What is the failure rate of the Cartiva implant?

Independent studies suggest failure rates between 60 and 79 percent-far higher than the 13 percent reported during FDA approval. Many patients experienced pain, instability, and the need for additional surgery within a few years of implantation.

What symptoms indicate my Cartiva implant has failed?

Watch for recurring pain, swelling, stiffness, or clicking in the big toe joint. Difficulty walking, bone erosion visible on X-ray, or the return of arthritis-like symptoms often signal implant loosening or movement.

How much are Cartiva lawsuit settlements expected to be?

No settlements have been finalized yet, but early projections suggest substantial payouts for patients requiring revision surgeries or fusion. Compensation will likely vary based on injury severity, medical expenses, and long-term disability.

What is the timeline for Cartiva lawsuits?

The first trials are expected to begin in late 2025, with potential settlement discussions beforehand. Many anticipate broader resolution by 2026 once early bellwether trials set precedent. Filing your claim now ensures you’re part of any negotiated settlement.

Do I need to pay upfront legal fees?

No. Our firm works entirely on contingency. We advance all case costs and only get paid if we recover money for you. This allows every patient to pursue justice regardless of financial situation.

Related Resources on Cartiva Implant Failures and Lawsuits

• Cartiva Implant Failed – What Patients Wish They Knew Before Surgery
• Is It Too Late to File a Cartiva Lawsuit? Understanding Your Legal Deadlines
• Cartiva vs Toe Fusion – Why Surgeons Are Now Saying Go Back to Basics
• The Hidden Costs of a Failed Cartiva Implant – Pain, Lost Work, and Endless Medical Bills
• Inside the Cartiva Lawsuits – What Lawyers Are Discovering About Device Failures
• How to Tell if Your Cartiva Implant Is Failing (and What to Do About It)
• From Innovation to Injury – The Rise and Fall of the Cartiva Toe Implant
• Why the Cartiva Recall Could Be Bigger Than Anyone Expected

Each of these in-depth resources explores a different part of the Cartiva story – from early optimism and surgical marketing to the growing wave of lawsuits and recall litigation. Together, they form a complete guide for patients seeking answers about Cartiva implant failures, revision options, and legal rights.